17% of patients had germline protein-truncating variants (PTVs), with biallelic inactivation happening in ~4% of these patiences due to further somatic alteration on top of a germline PTV affecting known cancer-predisposition genes (such as BRCA1, BRCA2, and ATM). This evidence concerns the gene BRCA2 and cancer.